Foundation for innovation
in Cardiometabolism and Nutrition

Research

  • MEDITWIN: using digital twins to develop tomorrow’s personalized medicine

    MEDITWIN: using digital twins to develop tomorrow’s personalized medicine

  • IHU ICAN launches its barometer on cardiometabolic diseases with IFOP

    IHU ICAN launches its barometer on cardiometabolic diseases with IFOP

  • Type 2 diabetes: link between aortic flow and epicardial fat discovered

    Type 2 diabetes: link between aortic flow and epicardial fat discovered

  • How to optimize decision making for defibrillator implantation in hypertrophic cardiomyopathy?

    How to optimize decision making for defibrillator implantation in hypertrophic cardiomyopathy?

  • The SINBAD score, a useful tool for predicting major adverse foot events in diabetic patients?

    The SINBAD score, a useful tool for predicting major adverse foot events in diabetic patients?

  • New funding from the Health Data Hub (Bpifrance) for the ANNITIA and CardiHACK projects!

    New funding from the Health Data Hub (Bpifrance) for the ANNITIA and CardiHACK projects!

  • Sarcopenic obesity: a new diagnostic method using artificial intelligence

    Sarcopenic obesity: a new diagnostic method using artificial intelligence

  • IHU ICAN and MSDAVENIR sign a strategic partnership in medical imaging (ICONIC project)

    IHU ICAN and MSDAVENIR sign a strategic partnership in medical imaging (ICONIC project)

  • SEQUOIA-HCM: Launch of an international multicenter study to investigate a potential new therapy for hypertrophic cardiomyopathy

    SEQUOIA-HCM: Launch of an international multicenter study to investigate a potential new therapy for hypertrophic cardiomyopathy

  • Epigenetics: induced pluripotent stem cells, a promising cellular model for studying parental imprinting diseases

    Epigenetics: induced pluripotent stem cells, a promising cellular model for studying parental imprinting diseases

ISO 9001 Certified

OUr Institutionnal Supporters

Our network